Kjell Eneslätt

Kontakt

kjell.eneslatt@umu.se

090-785 46 59

Verksam som

Forskningsingenjör vid Institutionen för klinisk mikrobiologi Enhet: Avdelningen för infektion och immunologi

by 6, Universitetssjukhuset, Klin bakt, 6D/2A Umeå universitet, 901 85 Umeå SE

Tularemia and tularemia vaccination induce similar, yet partially distinct, multifunctional T-cell responses

Frontiers in Immunology, Frontiers Media S.A. 2026, Vol. 17

Lindgren, Helena; Eneslätt, Kjell; Sjöstedt, Anders

Modulatory role of ATG5 protein in immune modulation during experimental tularemia

Microorganisms, MDPI 2026, Vol. 14, (7)

Mihelčić, Mirna; Viduka, Ina; Antonić, Maša; et al.

Kinetics of the serological response up to one year after tularemia

Frontiers in Cellular and Infection Microbiology, Frontiers Media S.A. 2023, Vol. 12

Lindgren, Helena; Eklund, Johan; Eneslätt, Kjell; et al.

Analyses of human immune responses to Francisella tularensis identify correlates of protection

Frontiers in Immunology, Frontiers Media S.A. 2023, Vol. 14

Lindgren, Helena; Eneslätt, Kjell; Golovliov, Igor; et al.

Vaccine-Mediated Mechanisms Controlling Francisella tularensis SCHU S4 Growth in a Rat Co-Culture System

Pathogens, MDPI 2020, Vol. 9, (5)

Lindgren, Helena; Eneslätt, Kjell; Golovliov, Igor; et al.

Guanylate-Binding Proteins Are Critical for Effective Control of Francisella tularensis Strains in a Mouse Co-Culture System of Adaptive Immunity

Frontiers in Cellular and Infection Microbiology, Frontiers Media S.A. 2020, Vol. 10

Mohammadi, Nasibeh; Lindgren, Helena; Golovliov, Igor; et al.

Vaccine-mediated mechanisms controlling replication of Francisella tularensis in human peripheral blood mononuclear cells using a co-culture system

Frontiers in Cellular and Infection Microbiology, Frontiers Media S.A. 2018, Vol. 8

Eneslätt, Kjell; Golovliov, Igor; Rydén, Patrik; et al.

Peptidoglycan-associated lipoprotein of Aggregatibacter actinomycetemcomitans induces apoptosis and production of proinflammatory cytokines via TLR2 in murine macrophages RAW 264.7 in vitro

Journal of Oral Microbiology, Taylor & Francis 2018, Vol. 10

Ihalin, Riikka; Eneslatt, Kjell; Asikainen, Sirkka

An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy

Frontiers in Cellular and Infection Microbiology, Vol. 6

Golovliov, Igor; Lindgren, Helena; Eneslätt, Kjell; et al.

Importance of PdpC, IglC, IglI, and IglG for Modulation of a Host Cell Death Pathway Induced by Francisella tularensis

Infection and Immunity, Vol. 81, (6) : 2076-2084

Lindgren, Marie; Eneslätt, Kjell; Bröms, Jeanette; et al.

Signatures of T cells as correlates of immunity to Francisella tularensis

PLOS ONE, Vol. 7, (3) : e32367-

Eneslätt, Kjell; Normark, Monica; Björk, Rafael; et al.

Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis

European Journal of Immunology, Weinheim: Wiley-VCH Verlagsgesellschaft 2011, Vol. 41, (4) : 974-980

Eneslätt, Kjell; Rietz, Cecilia; Rydén, Patrik; et al.

Vesicle-independent extracellular release of a proinflammatory outer membrane lipoprotein in free-soluble form

BMC Microbiology, Vol. 28, (8:18)

Karched, Maribasappa; Ihalin, Rikka; Eneslätt, Kjell; et al.

Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus

Lupus, Vol. 12, (10) : 766-774

Eriksson, Catharina; Eneslätt, Kjell; Ivanoff, J; et al.

Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases

Journal of Clinical Immunology, Vol. 22, (4) : 220-227

Christensson, Marta; Pettersson, Erna; Eneslätt, Kjell; et al.

The regulation of FasL expression: a distinguishing feature between monocytes and T lymphocytes/NK cells with possible implications for SLE

Journal of Clinical Immunology, Vol. 21, (3) : 183-192

Eneslätt, Kjell; Rantapää-Dahlqvist, Solbritt; Uddhammar, Agneta; et al.

Visa publikationer i DiVA

Forskargrupper

Gruppmedlem

Anders Sjöstedt

Forskningsprojekt

1 januari 2021 till 31 december 2025

Utveckling av ett tularemivaccin